An observational study in Status Epilepticus, sponsored by Ictal Group. Recruiting at 20 sites in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-10-22.
Sponsored by Ictal Group · Observational
Convulsive and Non Convulsive Status Epilepticus (SE) and Pseudo Status Epilepticus prospective registry.
Data collection using a standardized form : demographic data and data related to the SE, including circumstances of onset, dates and times of onset and of seizure control, on-scene clinical findings, clinical features of the seizures, pre-hospital and hospital care providers, timing of antiepileptic and supportive treatments, results of etiological investigations, cause of SE, type and dosage of antiepileptic drugs. Dates and times of EEG monitoring, EEG results. Outcomes including vital status and Glasgow Outcome Scale score at ICU and hospital discharge, day-90 and 1-year after SE and determined based on data in the ICU and/or neurologist charts and/or patients phone interview.
124 studies on the registry are indexed under Status Epilepticus; 37 are open to participants now.
This study's planned enrollment of 1,000 is above the median of 156 across 42 observational studies indexed under Status Epilepticus.
Browse Status Epilepticus studies →Ictal Group is the lead sponsor of 4 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
critically ill patients requiring ICU hospitalisation
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Convulsive and Non-Convulsive Status Epilepticus ; and Pseudo Status Epilepticus
Favorable outcome
A favorable outcome is defined by a Glasgow Outcome Scale (GOS) of 5. The Glasgow Outcome Scale (GOS) will be determined according to patients charts review and/or general practitioner interview conducted by an independent assessor. The GOS score : \[1: Death, 2: Persistent vegetative state, 3: Severe disability, 4: Moderate disability, 5 : Low disability\]
Time frame: 1 year
Favorable outcome
A favorable outcome is defined by a Glasgow Outcome Scale (GOS) of 5. The Glasgow Outcome Scale (GOS) will be determined patients charts review and/or general practitioner interview conducted by an independent assessor. The GOS score : \[1: Death, 2: Persistent vegetative state, 3: Severe disability, 4: Moderate disability, 5 : Low disability\]
Time frame: 3 months, 5-years and 10 years
Functional impairment
Percentages of the patients that experience functional impairment (motor, sensitive, cognitive, epilepsy)
Time frame: 3 months, and 1-year, 5-years and 10-years
total seizure duration
total seizure duration in minutes
Time frame: 72 hours
percentages of the patients that experience recurrent convulsive and/or non-convulsive seizures within 12 hours after ICU admission
Time frame: 12 hours
refractory status epilepticus
Time frame: 24 hours
super refractory status epilepticus
Time frame: 72 hours
total ICU and in-hospital length of stay
total ICU and in-hospital length of stay in days
Time frame: 90 days
mortality rate
Time frame: ICU and hospital discharge, 3-months, and 1-year, 5 years and 10 years
Plan to share: Undecided
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.